Location History:
- Victoria, AU (2012)
- Notting Hill, AU (2013)
Company Filing History:
Years Active: 2012-2013
Title: Saba Jahangiri: Innovator in Viral Therapeutics
Introduction
Saba Jahangiri is a notable inventor based in Notting Hill, Australia. He has made significant contributions to the field of viral therapeutics, particularly in the development of polymerase inhibitors and nucleoside analogs. With a total of 2 patents to his name, Jahangiri is recognized for his innovative approaches to combating viral infections.
Latest Patents
Jahangiri's latest patents include groundbreaking work on viral polymerase inhibitors. This invention relates to inhibitors of formula (I), which are designed to treat Flaviviridae viral infections, such as Hepatitis C virus (HCV) infections. His second patent focuses on bicyclic nucleosides and nucleotides as therapeutic agents. This disclosure outlines methods for the manufacture and use of these compounds in the treatment and prevention of infectious and proliferative diseases, including microbial infections and cancer.
Career Highlights
Saba Jahangiri is currently associated with Biota Scientific Management Pty Ltd, where he continues to advance his research in viral therapeutics. His work has garnered attention for its potential impact on public health, particularly in the treatment of viral infections.
Collaborations
Jahangiri collaborates with esteemed colleagues, including Barbara Frey and Alistair George Draffan. These partnerships enhance the research and development efforts within his field, fostering innovation and progress.
Conclusion
Saba Jahangiri stands out as an influential inventor in the realm of viral therapeutics. His contributions through innovative patents and collaborations highlight his commitment to advancing medical science.